Betta Pharmaceuticals: The latest data from the global multi-center first-line Phase III clinical study of Ensatinib has not been released yet

Post date May 16, 2022 — 11:15 Post Lock

Key Data Concepts:
? These are the company names, stock quotes, topics, and entities related to this data.

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Related Data

Betta Pharmaceuticals: Conmana will implement medical insurance pricing from January 1, 2022 due to the inclusion of the indications of postoperative adjuvant therapy in the National Medical Insurance Catalogue

May 16, 2022 — 11:23

Betta Pharmaceuticals: The latest data from the global multi-center first-line Phase III clinical study of ensatinib has not yet been released

May 16, 2022 — 11:22

Betta Pharmaceuticals: The company's various business activities are carried out normally, the cash flow is healthy and stable, and the research projects are progressing smoothly

May 16, 2022 — 11:18

Betta Pharmaceuticals: The latest data from the global multi-center first-line Phase III clinical study of Ensatinib has not yet been released – yqqlm

May 16, 2022 — 11:16

Betta Pharmaceuticals: The company has established an effective internal control system and has always maintained high management capabilities_ Oriental Fortune Net

May 16, 2022 — 11:16

Its 19 active equity funds all fell by more than 19%. What happened to Yuanxin Yongfeng? Economic Review Rongyi Information Network

May 12, 2022 — 20:37

Its 19 active equity funds all fell by more than 19%! What happened to Yuanxin Yongfeng? Economic Review Rongyi Information Network

May 12, 2022 — 10:38

Three questions about Yifang Bio's IPO: False equity transfer? Patent disputes or compensation? Loss of 1.54 billion yuan and no sales? _Stock Information_Market_CICC Online

May 7, 2022 — 09:16

60 billion fell! After the two big brothers reduce their holdings, how should they look at the Internet stocks? _Stock Information_Market_CICC Online

May 4, 2022 — 21:57

Home » News » Betta Pharmaceuticals: The latest data from the global multi-center first-line Phase III clinical study of Ensatinib has not been released yet